Order Article Reprints

Grau G, Brunet-Mas E, Llovet LP, Pedregal P, Villoria A, Melcarne L, Puy A, Garcia-Sague B, Frisancho LE, Ramírez-Lázaro MJ, et al. Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital. Journal of Clinical Medicine. 2023; 12(20):6571. https://doi.org/10.3390/jcm12206571

Grau, Gerard, Eduard Brunet-Mas, Laura Patricia Llovet, Patricia Pedregal, Albert Villoria, Luigi Melcarne, Anna Puy, Belen Garcia-Sague, Luis Enrique Frisancho, María José Ramírez-Lázaro, and et al. 2023. "Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital" Journal of Clinical Medicine 12, no. 20: 6571. https://doi.org/10.3390/jcm12206571

Grau, G., Brunet-Mas, E., Llovet, L. P., Pedregal, P., Villoria, A., Melcarne, L., Puy, A., Garcia-Sague, B., Frisancho, L. E., Ramírez-Lázaro, M. J., Lario, S., & Calvet, X. (2023). Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital. Journal of Clinical Medicine, 12(20), 6571. https://doi.org/10.3390/jcm12206571